Influence of sub-health fatigue serum on the activity of cytochrome C oxidase and energy charge of mitochondrial membrane of human skeletal muscle cells

Journal of Clinical Rehabilitative Tissue Engineering Research

Volumn 12, Issue 37, 2008, Pages 7258-7262

  Li, Bao Liang ^a   Zhao, Xiao Shan ^b   Luo, Ren ^b   Sun, Xiao Min ^b   Li, Jun ^b   Chen, Jing ^b  

^a Changzhou Hospital of Traditional Chinese Medicine   (China)

^b SOUTHERN MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE DIPHOSPHATE; ADENOSINE PHOSPHATE; CYTOCHROME C OXIDASE;

ADULT; ARTICLE; BIOCHEMISTRY; CLINICAL ARTICLE; CONCENTRATION RESPONSE; CONTROLLED STUDY; CULTURE MEDIUM; ENERGY; ENZYME ACTIVITY; FATIGUE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; HUMAN CELL; HUMAN CELL CULTURE; IN VITRO STUDY; MALE; MITOCHONDRIAL MEMBRANE; MUSCLE CELL; SERUM; SKELETAL MUSCLE; VENOUS BLOOD;

EID: 56749159820     PISSN: 16738225     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (22)

1. Sun T,Zhao XS,Luo R.Zhongyiyao Guanli Zazhi 2004;14(3):59-60
2. McCully KK, Smith S, Rajaei S, et al. Blood flow and muscle metabolism in chronic fatigue syndrome. Clin Sci (Lond) 2003;104(6):641-647
3. McCully KK, Smith S, Rajaei S, et al. Muscle metabolism with blood flow restriction in chronic fatigue syndrome. J Appl Physiol 2004;96(3):871-878
4. 2+ in the skeletal muscle of chronic fatigue syndrome patients. Dyn Med 2006;5:1
5. Meeus M, Nijs J, McGregor N, et al. Unravelling intracellular immune dysfunctions in chronic fatigue syndrome: interactions between protein kinase R activity, RNase L cleavage and elastase activity, and their clinical relevance. In Vivo 2008;22(1):115-121
6. Maes M, Mihaylova I, Leunis JC. Increased serum IgM antibodies directed against phosphatidyl inositol(Pi) in chronic fatigue syndrome(CFS) and major depression: evidence that an IgM-mediated immune response against Pi is one factor underpinning the comorbidity between both CFS and depression. Neuro Endocrinol Lett 2007;28(6):861-867
7. Mihaylova I, DeRuyter M, Rummens JL, et al. Decreased expression of CD69 in chronic fatigue syndrome in relation to inflammatory markers: evidence for a severe disorder in the early activation of T lymphocytes and natural killer cells. Neuro Endocrinol Lett 2007;28(4):477-483
8. Richards RS, Wang L, Jelinek H. Erythrocyte oxidative damage in chronic fatigue syndrome. Arch Med Res 2007;38(1):94-98
9. Maes M, Mihaylova I, Leunis JC. Chronic fatigue syndrome is accompanied by an IgM-related immune response directed against neopitopes formed by oxidative or nitrosative damage to lipids and proteins. Neuro Endocrinol Lett 2006;27(5):615-621
10. Kerr JR, Petty R, Burke B,et al. Gene Expression Subtypes in Patients with Chronic Fatigue Syndrome/Myalgic Encephalomyelitis. J Infect Dis 2008;197(8):1171-1184
11. Maes M, Mihaylova I, Kubera M, et al. Not in the mind but in the cell: increased production of cyclo-oxygenase-2 and inducible NO synthase in chronic fatigue syndrome. Neuro Endocrinol Lett 2007;28(4):463-469
12. Patarca R. Cytokines and chronic fatigue syndrome. Ann N Y Acad Sci 2001;933:185-200
13. Moss RB,Mercandetti A,Vojdani A. TNF-alpha and chronic fatigue syndrome. J Clin Immunol 1999;19(5):314-316
14. Zhao XS, Luo R,Zhang XQ,et al.Zhongguo Xiandai Yixue Zazhi 2007;17(3): 285-286
15. Dai FG,Zhao XS,Luo R,et al.Zhongguo Linchuang Kangfu 2005;9(19): 97-99
16. Sun XM,Li XY,Jin W,et al.Sichuan Zhongyi 2008;26(4):7-9
17. Zhonghua Zhongyiyao Xuehui.Beijing:Zhongguo Zhongyiyao Publishing House 2006:1-2
18. Bogenhagen D, Clayton DA. The number of mitochondrial deoxyribonucleic acid genomes in mouse L and human HeLa cells. Quantitative isolation of mitochondrial deoxyribonucleic acid. J Biol Chem 1974;249(24):7991-7995
19. Aksenov MY, Tucker HM, Nair P,et al. The expression of several mitochondrial and nuclear genes encodinn the subunits of electron transport chain enzyme complexes cytochrome C oxidase, and NADH dehydrogenase, in different brain regions in Alzheimer's disease. Neurochem.Res 1999;24:767-774
20. Zhong RH.Shandong Tiyu Xueyuan Xuebao 1997;13(3):28-31
21. Ma ZW,Wang SL,Wang FJ,et al.Xiaohua Waike 2002;1(5):311-314
22. Xu M,Cai GL,Li RY.Chengdu Tiyu Xueyuan Xuebao 2005;31(4):91-96